Amphastar Pharmaceuticals Current Ratio 2012-2020 | AMPH

Amphastar Pharmaceuticals current ratio from 2012 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Amphastar Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $0.25B $0.08B 2.96
2019-12-31 $0.26B $0.09B 2.84
2019-09-30 $0.27B $0.09B 3.11
2019-06-30 $0.28B $0.10B 2.81
2019-03-31 $0.23B $0.11B 2.06
2018-12-31 $0.22B $0.11B 2.06
2018-09-30 $0.20B $0.10B 2.02
2018-06-30 $0.17B $0.09B 1.94
2018-03-31 $0.17B $0.07B 2.40
2017-12-31 $0.19B $0.07B 2.80
2017-09-30 $0.18B $0.06B 3.08
2017-06-30 $0.19B $0.06B 3.04
2017-03-31 $0.19B $0.07B 2.63
2016-12-31 $0.18B $0.06B 3.04
2016-09-30 $0.19B $0.06B 3.13
2016-06-30 $0.18B $0.07B 2.76
2016-03-31 $0.17B $0.07B 2.67
2015-12-31 $0.18B $0.06B 2.93
2015-09-30 $0.20B $0.07B 2.82
2015-06-30 $0.20B $0.07B 2.94
2015-03-31 $0.20B $0.07B 2.81
2014-12-31 $0.20B $0.06B 3.16
2014-09-30 $0.22B $0.06B 3.41
2014-06-30 $0.21B $0.06B 3.81
2014-03-31 $0.18B $0.07B 2.44
2013-12-31 $0.17B $0.07B 2.65
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.17B $0.06B 2.76
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2012-03-31 $0.00B 0.00
2011-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $1.013B $0.322B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $12.396B 4.60
Dr Reddy's Laboratories (RDY) India $8.763B 20.98
Mylan (MYL) United States $8.235B 3.54
Bausch Health Cos (BHC) Canada $6.508B 4.31
ASPEN PHARMACR (APNHY) South Africa $3.852B 0.00
BridgeBio Pharma (BBIO) United States $3.612B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.240B 10.88
Assembly Biosciences (ASMB) United States $0.759B 0.00
Homology Medicines (FIXX) United States $0.694B 0.00
Voyager Therapeutics (VYGR) United States $0.480B 0.00
Personalis (PSNL) United States $0.451B 0.00
CymaBay Therapeutics (CBAY) United States $0.241B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.205B 0.28
Sol-Gel Technologies (SLGL) Israel $0.177B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.087B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.072B 0.00
Akorn (AKRXQ) United States $0.052B 2.79
Teligent (TLGT) United States $0.014B 0.00